NervGen Pharma (NGEN) Price & Analysis

Compare

49 Followers

NGEN Stock Chart & Stats

Day’s Range― - ―

52-Week RangeC$2.05 - C$7.05

Previous CloseN/A

Volume11.98K

Average Volume (3M)79.42K

Market Cap

$276.99M

Enterprise ValueC$231.86M

Total Cash (Recent Filing)$15.73M

Total Debt (Recent Filing)$57.71K

Price to Earnings (P/E)―

Beta-0.21

Next Earnings

Nov 13, 2025

EPS Estimate

-0.07

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.13

Shares Outstanding73,277,290

10 Day Avg. Volume66,845

30 Day Avg. Volume79,425

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.84

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-8.31K

Enterprise Value/Ebitda-8.78

Forecast

1Y Price Target

$10.22

Price Target Upside170.45% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

NervGen Pharma News

NervGen Pharma Reports Breakthrough in Spinal Cord Injury Treatment

NervGen Pharma ( ($TSE:NGEN) ) just unveiled an update. NervGen Pharma announced groundbreaking results from its Phase 1b/2a...

12d ago

NervGen Pharma’s NVG-291-R Shows Promising Preclinical Results in Nerve Repair

NervGen Pharma ( ($TSE:NGEN) ) has issued an announcement. NervGen Pharma announced positive preclinical results for its drug...

17d ago

NervGen Pharma Announces Leadership Change Amid Positive Trial Results

An update from NervGen Pharma ( ($TSE:NGEN) ) is now available. NervGen Pharma has announced a leadership transition...

2M ago

NervGen Pharma Updates on Equity Program and Stock Options

NervGen Pharma ( ($TSE:NGEN) ) has issued an announcement. NervGen Pharma Corp. updated on its at-the-market equity program,...

2M ago

NervGen Pharma Strengthens Leadership Amid Positive Trial Results

NervGen Pharma ( ($TSE:NGEN) ) has shared an announcement. NervGen Pharma has appointed Dr. Adam Rogers as the...

2M ago

NervGen Pharma Announces Leadership Transition Amid NVG-291 Advancements

NervGen Pharma ( ($TSE:NGEN) ) has provided an update. NervGen Pharma announced a leadership transition as Daniel Mikol,...

2M ago

NervGen Pharma Appoints Dr. Randall Kaye as Chief Medical Advisor

NervGen Pharma ( ($TSE:NGEN) ) has provided an announcement. NervGen Pharma has appointed Dr. Randall Kaye as Chief...

3M ago

NervGen Pharma price target raised to C$6 from C$4.50 at Raymond James

Raymond James analyst Michael Freeman raised the firm’s price target on NervGen Pharma (NGENF) to C$6 from C$4.50...

3M ago

NervGen Pharma price target raised to C$5 from C$4.50 at Stifel

Stifel raised the firm’s price target on NervGen Pharma (NGENF) to C$5 from C$4.50 and keeps a Buy...

3M ago

NervGen Pharma Announces Breakthrough Results in Spinal Cord Injury Treatment Trial

An announcement from NervGen Pharma ( ($TSE:NGEN) ) is now available. NervGen Pharma announced positive topline results from...

3M ago

NervGen reports topline data from chronic cohort of Phase 1b/2a trial of NVG-291

NervGen Pharma (NGENF) announced topline results from the chronic cohort of its Phase 1b/2a clinical trial evaluating its...

3M ago

NervGen Pharma to Present Promising NVG-291 Study Results at ASIA Meeting

NervGen Pharma ( ($TSE:NGEN) ) has shared an update. NervGen Pharma announced that it will present topline results...

4M ago

NervGen Pharma Awards Stock Options to Directors and Employees

NervGen Pharma ( ($TSE:NGEN) ) just unveiled an announcement. NervGen Pharma has granted 600,000 incentive stock options to...

4M ago

NervGen Pharma price target raised to C$4.50 from C$3 at Raymond James

Raymond James analyst Michael Freeman raised the firm’s price target on NervGen Pharma (NGENF) to C$4.50 from C$3...

8M ago

NGEN FAQ

What was NervGen Pharma’s price range in the past 12 months?

NervGen Pharma lowest stock price was C$2.05 and its highest was C$7.05 in the past 12 months.

What is NervGen Pharma’s market cap?

NervGen Pharma’s market cap is $276.99M.

When is NervGen Pharma’s upcoming earnings report date?

NervGen Pharma’s upcoming earnings report date is Nov 13, 2025 which is in 67 days.

How were NervGen Pharma’s earnings last quarter?

NervGen Pharma released its earnings results on Aug 26, 2025. The company reported -C$0.13 earnings per share for the quarter, missing the consensus estimate of -C$0.075 by -C$0.055.

Is NervGen Pharma overvalued?

According to Wall Street analysts NervGen Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does NervGen Pharma pay dividends?

NervGen Pharma does not currently pay dividends.

What is NervGen Pharma’s EPS estimate?

NervGen Pharma’s EPS estimate is -0.07.

How many shares outstanding does NervGen Pharma have?

NervGen Pharma has 73,277,290 shares outstanding.

What happened to NervGen Pharma’s price movement after its last earnings report?

NervGen Pharma reported an EPS of -C$0.13 in its last earnings report, missing expectations of -C$0.075. Following the earnings report the stock price went down -3.005%.

Which hedge fund is a major shareholder of NervGen Pharma?

Currently, no hedge funds are holding shares in TSE:NGEN

NervGen Pharma Stock Smart Score

Outperform

Fundamentals

Return on Equity

-457.00%

Trailing 12-Months

Asset Growth

-39.15%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

NervGen Pharma

NervGen Pharma Corp (NGEN) is a biotechnology company focused on discovering and developing innovative solutions for the treatment of nerve damage and neurodegenerative diseases. Operating within the biopharmaceutical sector, the company's core products include therapeutic treatments aimed at enhancing neural repair and regeneration to address conditions such as spinal cord injury, multiple sclerosis, and Alzheimer's disease.

NervGen Pharma (NGEN) Earnings & Revenues

Historic Earnings Reports

NGEN Stock 12 Month Forecast

Average Price Target

C$10.22

▲(170.45% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"C$0","21":"C$21","5.25":"C$5.25","10.5":"C$10.5","15.75":"C$15.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20.196906058,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$20.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.2229545047,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$10.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.00000001435795,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,5.25,10.5,15.75,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Nov<br/>2024","9":"Apr<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.4,4.692069696769231,5.984139393538461,7.276209090307693,8.568278787076924,9.860348483846154,11.152418180615385,12.444487877384617,13.736557574153847,15.028627270923078,16.320696967692307,17.61276666446154,18.90483636123077,{"y":20.196906058,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.4,3.9248426542076924,4.4496853084153845,4.9745279626230765,5.4993706168307686,6.024213271038461,6.5490559252461535,7.0738985794538465,7.5987412336615385,8.12358388786923,8.648426542076923,9.173269196284615,9.698111850492307,{"y":10.2229545047,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.4,3.523076924181381,3.6461538483627614,3.7692307725441423,3.8923076967255232,4.015384620906904,4.138461545088285,4.261538469269666,4.384615393451046,4.5076923176324275,4.630769241813808,4.7538461659951885,4.87692309017657,{"y":5.00000001435795,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.94,"date":1656633600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.93,"date":1661990400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.05,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.95,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.89,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.98,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.88,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.14,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.55,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.44,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >